Form 4: Seer, Inc. Director Meeta Gulyani Granted Significant Equity Awards

Seer, Inc. Director Meeta Gulyani was granted 20,500 restricted stock units and options to purchase 30,500 shares of Class A Common Stock, vesting over the next year.

Summary

• Meeta Gulyani, a Director of Seer, Inc., was granted equity awards on July 7, 2025.
• The awards include 20,500 shares of Class A Common Stock in the form of restricted stock units (RSUs), granted at a price of $0.
• Additionally, 30,500 stock options were granted with an exercise price of $2.18 per share, also granted at a price of $0.
• Both the RSUs and stock options are scheduled to vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
• Following these transactions, Meeta Gulyani directly beneficially owns 107,543 shares of Class A Common Stock and 30,500 stock options.
• The granted stock options have an expiration date of July 7, 2035.

Sentiment

Score: 6

Explanation: Slightly positive. The grant of equity to a director indicates continued commitment and alignment of interests with shareholders, which is generally viewed favorably. However, it's a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of equity awards to a director aligns their interests with long-term shareholder value, incentivizing commitment to the company's performance.
• The acquisition of additional shares (via RSUs) and options increases the director's direct stake in the company, demonstrating confidence.

Negatives

• Future vesting of RSUs and exercise of options will lead to some dilution for existing shareholders when the shares are issued.

Risks

• Potential future dilution for existing shareholders from the vesting of 20,500 restricted stock units and the exercise of 30,500 stock options.

Future Outlook

The granted restricted stock units and stock options are scheduled to vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders, indicating a future increase in the director's vested equity stake. The stock options have an expiration date of July 7, 2035, providing a long-term incentive horizon.

Industry Context

This Form 4 filing details an equity grant to a director, which is a common practice in the biotechnology and life sciences industry (where Seer, Inc. operates) to compensate and incentivize board members. Such grants align director interests with long-term company performance, a standard corporate governance practice across industries.

Comparison to Industry Standards

• Equity grants to directors are a standard component of compensation packages in publicly traded companies, particularly in high-growth sectors like biotechnology.
• The vesting schedule, typically over one to three years, is common for director equity awards, aiming to retain talent and align long-term interests.
• The exercise price of $2.18 for options, when granted at a future date, would typically be the fair market value on the grant date, which is standard practice to avoid immediate taxable income for the recipient.
• While the document does not provide specific benchmarks, the size and structure of such grants are typically evaluated against compensation practices of peer companies within the biotechnology industry, considering factors like company size, performance, and director responsibilities.

Stakeholder Impact

• Shareholders: Potential future dilution upon vesting of RSUs and exercise of options. However, it also signals continued alignment of a director's interests with the company's long-term performance.
• Director (Meeta Gulyani): Receives significant equity compensation, incentivizing long-term commitment and performance.

Next Steps

• Vesting of 20,500 restricted stock units on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
• Vesting of 30,500 stock options on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
• Potential exercise of stock options by their expiration date of July 7, 2035.

Key Dates

Recommendation

Keywords

Seer Inc., SEER, Meeta Gulyani, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Director Compensation, Beneficial Ownership